Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock - $0.001 par value
-
Shares outstanding
-
10.6M
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
5.28M
-
Shares change
-
+258K
-
Total reported value, excl. options
-
$45.3M
-
Value change
-
+$2.35M
-
Number of buys
-
7
-
Number of sells
-
-7
-
Price
-
$8.58
Significant Holders of NEPHROS INC - Common Stock - $0.001 par value (NEPH) as of Q4 2020
17 filings reported holding NEPH - NEPHROS INC - Common Stock - $0.001 par value as of Q4 2020.
NEPHROS INC - Common Stock - $0.001 par value (NEPH) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.28M shares
of 10.6M outstanding shares and own 49.69% of the company stock.
Largest 10 shareholders include WEXFORD CAPITAL LP (3.56M shares), Cowen Prime Services LLC (575K shares), Samjo Capital LLC (550K shares), BARD ASSOCIATES INC (207K shares), Parkman Healthcare Partners LLC (167K shares), VANGUARD GROUP INC (67.4K shares), HighTower Advisors, LLC (55.7K shares), BLAIR WILLIAM & CO/IL (36.2K shares), MILLENNIUM MANAGEMENT LLC (21.1K shares), and BlackRock Inc. (19.5K shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.